@damccormick13@jordanmenard Alzchem is launching some creatine drinks and yogurts and such in Germany with ehrmann. Alzchem also has some creatine candies/mints internally. You guys thinking about bringing these to the US?
@deepvalueco@capitalatrisk23 New stores are negative working capital. No cash contraint on growth. Opening stores is opex contrained, double digit store growth is good enough. Already budgeting to enter US... Take the cash and buy back stock or buy more Action!
@vitaliyk In an ideal world the stock you sold keeps going up (you did choose a good business) but the company you bought to replace it goes up more (you made an incrementally better investment).
@UpslopeCapital On SJ, recently sold after holding for 5 years. Spot pricing in poles is 20-30% below contract rates. Contracts are ~4 years, covid bump about to roll. Management conflates distribution demand with transmission but volume could bail out pricing.
@AltaFoxCapital@LongVollllll@ValleyFallsRI There is also a high tendency to grow total company size at the expense of unit economics or shareholders. Governance reports like to benchmark management compensation to "similarly sized" companies.
@BlackSailsRsch@UpslopeCapital It also only has like 8 data streams. Their standard company data, estimates data, georev, etc. Not really any proprietary data is available on MCP
@DutchInvestors Fundamentals have changed slightly. Policy inflation has gone from a 3-5% tailwind to a -3-0% headwind. Topline growth will be slower for a while barring acceleration in M&A
@DutchInvestors Don't forget they have recently stepped into franchising with the intent to accelerate growth in new markets in a capital light format.
@UpslopeCapital Coco down 10% y/y. Down 45% from peak. It just hasn't worked its way through to the companies yet. 2-6 quarters lag
It's crazy how different the price elasticity has been for chocolate vs coffee. (Ignore GLP1, healthy eating, yada yada)